Physician profile
Jody Aronson
NPI 1205924180
$2,670.26
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,587 · 2020: $122 · 2021: $861 · 2022: $70.34 · 2023: $29.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $29.53.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $29.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $965.30 | 2019 | |
| Coloplast Corp | $714.58 | 2019-2021 | |
| Abbvie INC. | $244.52 | 2019-2023 | Liletta |
| Avion Pharmaceuticals | $146.45 | 2019-2022 | |
| Boston Scientific Corporation | $137.76 | 2019 | |
| Biom'Up France Sas | $120.00 | 2021 | |
| Therapeuticsmd, INC. | $86.79 | 2019-2020 | |
| Organon LLC | $70.86 | 2021-2022 | |
| Hologic Sales and Service, LLC | $63.75 | 2019-2023 | Acessa Provu System |
| Aspira Women'S Health INC | $28.62 | 2022 | |
| Allergan, INC. | $24.17 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $17.78 | 2021 | |
| Merck Sharp & Dohme LLC | $17.40 | 2019 | |
| Myovant Sciences INC. | $16.35 | 2021 | |
| Pfizer INC. | $15.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Aronson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.